Nasal Antisepsis for C. Auris Prevention
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorMary K Hayden
About this trial
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
Eligibility criteria
Qualifiers
History of C. auris colonization or infection
Patient in a participating facility
Disqualifiers
History of severe allergy to iodine-based products, defined as anaphylaxis or rash
Currently breastfeeding or pregnant
Non-English language speaking
Trial design
Treatments tested in this trial
- Povidone Iodine Topical
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mary K Hayden
Lead sponsor
Rush University Medical Center
Sponsor institution
Rush University Medical Center
Collaborator
RML Specialty Hospital
Collaborator
Source ClinicalTrials.gov